Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Quality of life of Bahraini women with breast cancer: a cross sectional study

Authors: Ghufran Ahmed Jassim, David L Whitford

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Breast cancer can impact survivors in many aspects of their life. Scarce information is currently available on the quality of life of cancer survivors in Bahrain. The objective of this study is to describe the quality of life of Bahraini women with breast cancer and its association with their sociodemographic and clinical data.

Methods

This is a cross sectional study in which the European Organization for Research and Treatment of Cancer Quality of Life Cancer Specific version translated into Arabic was administered to a random sample of 337 Bahraini women with breast cancer. Relevant descriptive statistics were computed for all items. The equality of means across the categories of each categorical independent variable was tested using parametric tests (ANOVA and independent t-test) or non-parametric tests (Kruskal Wallis and Mann Whitney tests) of association where appropriate.

Results

Of the total sample, 239 consented to participation. The mean and median age of participants were 50.2 (SD ± 11.1) and 48.0 respectively. Participants had a mean score for global health of 63.9 (95% CI 61.21-66.66). Among functional scales, social functioning scored the highest (Mean 77.5 [95% CI 73.65-81.38]) whereas emotional functioning scored the lowest (63.4 [95% CI 59.12-67.71]). The most distressing symptom on the symptom scales was fatigability (Mean 35.2 [95% CI 31.38-39.18]). Using the disease specific tool it was found that sexual functioning scored the lowest (Mean 25.9 [95% CI 70.23-77.90]). On the symptom scale, upset due to hair loss scored the highest (Mean 46.3 [95% CI 37.82-54.84]). Significant mean differences were noted for many functional and symptom scales.

Conclusion

Bahraini breast cancer survivors reported favorable overall global quality of life. Factors associated with a major reduction in all domains of quality of life included the presence of metastases, having had a mastectomy as opposed to a lumpectomy and a shorter time elapsed since diagnosis. Poorest functioning was noted in the emotional and sexual domains. The most bothersome symptoms were fatigability, upset due to hair loss and arm symptoms. This study identifies the categories of women at risk of poorer quality of life after breast cancer and the issues that most need to be addressed in this Middle East society.
Literature
2.
go back to reference Ferlay, Bray, Pisan: Globocan 2002: cancer Incidence, mortality and prevalence world wide version 2.0: IARC Cancer Base no. 5. 2004, Lyon: IARCPress Ferlay, Bray, Pisan: Globocan 2002: cancer Incidence, mortality and prevalence world wide version 2.0: IARC Cancer Base no. 5. 2004, Lyon: IARCPress
3.
go back to reference Najjar H, Easson A: "Age at diagnosis of breast cancer in Arab nations". Int J Surg. 2010, 8 (6): 448-452. 10.1016/j.ijsu.2010.05.012.CrossRefPubMed Najjar H, Easson A: "Age at diagnosis of breast cancer in Arab nations". Int J Surg. 2010, 8 (6): 448-452. 10.1016/j.ijsu.2010.05.012.CrossRefPubMed
4.
go back to reference Alsayyad J, Hamadeh R: Cancer incidence among the Bahraini population: a five-year (1998–2002) experience. Ann Saudi Med. 2007, 27 (4): 251-258. 10.4103/0256-4947.51491.CrossRefPubMed Alsayyad J, Hamadeh R: Cancer incidence among the Bahraini population: a five-year (1998–2002) experience. Ann Saudi Med. 2007, 27 (4): 251-258. 10.4103/0256-4947.51491.CrossRefPubMed
5.
go back to reference Fakhro AE, Fateha BE, al-Asheeri N, al-Ekri SA: Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 1999, 5 (3): 430-439. Fakhro AE, Fateha BE, al-Asheeri N, al-Ekri SA: Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 1999, 5 (3): 430-439.
6.
go back to reference Chiedozi LC, El-Hag IA, Kollur SM: Breast diseases in the Northern region of Saudi Arabia. Saudi Med J. 2003, 24 (6): 623-627.PubMed Chiedozi LC, El-Hag IA, Kollur SM: Breast diseases in the Northern region of Saudi Arabia. Saudi Med J. 2003, 24 (6): 623-627.PubMed
9.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85 (5): 365-376. 10.1093/jnci/85.5.365.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85 (5): 365-376. 10.1093/jnci/85.5.365.CrossRefPubMed
10.
go back to reference Awad MA, Denic S, El Taji H: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations. Ann N Y Acad Sci. 2008, 1138: 146-154. 10.1196/annals.1414.021.CrossRefPubMed Awad MA, Denic S, El Taji H: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations. Ann N Y Acad Sci. 2008, 1138: 146-154. 10.1196/annals.1414.021.CrossRefPubMed
12.
go back to reference Fayers PM: Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer. 2001, 37 (11): 1331-1334. 10.1016/S0959-8049(01)00127-7.CrossRefPubMed Fayers PM: Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer. 2001, 37 (11): 1331-1334. 10.1016/S0959-8049(01)00127-7.CrossRefPubMed
13.
go back to reference Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, Kim SH, Lee KM, Park SM, Yun YH: Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol. 2007, 18 (1): 173-182.CrossRefPubMed Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, Kim SH, Lee KM, Park SM, Yun YH: Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol. 2007, 18 (1): 173-182.CrossRefPubMed
14.
go back to reference Waldmann A, Pritzkuleit R, Raspe H, Katalinic A: The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. 2007, 16 (5): 767-776. 10.1007/s11136-006-9161-5.CrossRefPubMed Waldmann A, Pritzkuleit R, Raspe H, Katalinic A: The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. 2007, 16 (5): 767-776. 10.1007/s11136-006-9161-5.CrossRefPubMed
15.
go back to reference Hopwood P, Haviland J, Mills J, Sumo G, MB J: The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast. 2007, 16 (3): 241-251. 10.1016/j.breast.2006.11.003.CrossRefPubMed Hopwood P, Haviland J, Mills J, Sumo G, MB J: The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast. 2007, 16 (3): 241-251. 10.1016/j.breast.2006.11.003.CrossRefPubMed
16.
go back to reference Montazeri A, Vahdaninia M, Harirchi I, Ebrahimi M, Khaleghi F, Jarvandi S: Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer. 2008, 8: 330-10.1186/1471-2407-8-330.CrossRefPubMedPubMedCentral Montazeri A, Vahdaninia M, Harirchi I, Ebrahimi M, Khaleghi F, Jarvandi S: Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer. 2008, 8: 330-10.1186/1471-2407-8-330.CrossRefPubMedPubMedCentral
17.
go back to reference Alawadi SA, Ohaeri JU: Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire. BMC Cancer. 2009, 9: 222-10.1186/1471-2407-9-222.CrossRefPubMedPubMedCentral Alawadi SA, Ohaeri JU: Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire. BMC Cancer. 2009, 9: 222-10.1186/1471-2407-9-222.CrossRefPubMedPubMedCentral
18.
go back to reference Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H: Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol. 2005, 23 (22): 4945-4953. 10.1200/JCO.2005.03.475.CrossRefPubMed Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H: Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol. 2005, 23 (22): 4945-4953. 10.1200/JCO.2005.03.475.CrossRefPubMed
19.
go back to reference Casso D, Buist DS, Taplin S: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes. 2004, 2: 25-10.1186/1477-7525-2-25.CrossRefPubMedPubMedCentral Casso D, Buist DS, Taplin S: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes. 2004, 2: 25-10.1186/1477-7525-2-25.CrossRefPubMedPubMedCentral
20.
21.
go back to reference King MT, Fayers PM: Making quality-of-life results more meaningful for clinicians. Lancet. 2008, 371 (9614): 709-710. 10.1016/S0140-6736(08)60324-4.CrossRefPubMed King MT, Fayers PM: Making quality-of-life results more meaningful for clinicians. Lancet. 2008, 371 (9614): 709-710. 10.1016/S0140-6736(08)60324-4.CrossRefPubMed
22.
go back to reference Schwarz R, Hinz A: Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001, 37 (11): 1345-1351. 10.1016/S0959-8049(00)00447-0.CrossRefPubMed Schwarz R, Hinz A: Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001, 37 (11): 1345-1351. 10.1016/S0959-8049(00)00447-0.CrossRefPubMed
23.
go back to reference Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR: Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002, 77 (4): 371-383. 10.4065/77.4.371.CrossRefPubMed Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR: Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002, 77 (4): 371-383. 10.4065/77.4.371.CrossRefPubMed
24.
go back to reference Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR: Body image and sexual problems in young women with breast cancer. Psychooncology. 2006, 15 (7): 579-594. 10.1002/pon.991.CrossRefPubMed Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR: Body image and sexual problems in young women with breast cancer. Psychooncology. 2006, 15 (7): 579-594. 10.1002/pon.991.CrossRefPubMed
25.
go back to reference Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV: Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005, 41 (17): 2613-2619. 10.1016/j.ejca.2005.05.017.CrossRefPubMed Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV: Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005, 41 (17): 2613-2619. 10.1016/j.ejca.2005.05.017.CrossRefPubMed
26.
go back to reference Sbitti Y, Kadiri H, Essaidi I, Fadoukhair Z, Kharmoun S, Slimani K, Ismaili N, Ichou M, Errihani H: Breast cancer treatment and sexual dysfunction: Moroccan women’s perception. BMC Womens Health. 2011, 11: 29-10.1186/1472-6874-11-29.CrossRefPubMedPubMedCentral Sbitti Y, Kadiri H, Essaidi I, Fadoukhair Z, Kharmoun S, Slimani K, Ismaili N, Ichou M, Errihani H: Breast cancer treatment and sexual dysfunction: Moroccan women’s perception. BMC Womens Health. 2011, 11: 29-10.1186/1472-6874-11-29.CrossRefPubMedPubMedCentral
27.
go back to reference Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA: Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol. 2003, 21 (21): 4027-4033. 10.1200/JCO.2003.08.097.CrossRefPubMed Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA: Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol. 2003, 21 (21): 4027-4033. 10.1200/JCO.2003.08.097.CrossRefPubMed
28.
go back to reference Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP, Neugut AI, Hershman DL, Mandelblatt J, Pelayo MP, Timperi AW, Miles SQ: Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010, 123 (2): 507-524. 10.1007/s10549-010-0764-8.CrossRefPubMedPubMedCentral Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP, Neugut AI, Hershman DL, Mandelblatt J, Pelayo MP, Timperi AW, Miles SQ: Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010, 123 (2): 507-524. 10.1007/s10549-010-0764-8.CrossRefPubMedPubMedCentral
29.
go back to reference Cimprich B, Ronis DL, Martinez-Ramos G: Age at diagnosis and quality of life in breast cancer survivors. Cancer Pract. 2002, 10 (2): 85-93. 10.1046/j.1523-5394.2002.102006.x.CrossRefPubMed Cimprich B, Ronis DL, Martinez-Ramos G: Age at diagnosis and quality of life in breast cancer survivors. Cancer Pract. 2002, 10 (2): 85-93. 10.1046/j.1523-5394.2002.102006.x.CrossRefPubMed
30.
go back to reference Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D: Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004, 10 (3): 223-231. 10.1111/j.1075-122X.2004.21323.x.CrossRefPubMed Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D: Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004, 10 (3): 223-231. 10.1111/j.1075-122X.2004.21323.x.CrossRefPubMed
31.
go back to reference van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H: Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst. 2000, 92 (14): 1143-1150. 10.1093/jnci/92.14.1143.CrossRefPubMed van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H: Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst. 2000, 92 (14): 1143-1150. 10.1093/jnci/92.14.1143.CrossRefPubMed
32.
go back to reference Buijs C, de Vries EG, Mourits MJ, Willemse PH: The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev. 2008, 34 (7): 640-655. 10.1016/j.ctrv.2008.04.001.CrossRefPubMed Buijs C, de Vries EG, Mourits MJ, Willemse PH: The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev. 2008, 34 (7): 640-655. 10.1016/j.ctrv.2008.04.001.CrossRefPubMed
33.
go back to reference Kornblith AB, Herndon JE, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF: Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003, 98 (4): 679-689. 10.1002/cncr.11531.CrossRefPubMed Kornblith AB, Herndon JE, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF: Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003, 98 (4): 679-689. 10.1002/cncr.11531.CrossRefPubMed
34.
go back to reference Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M: Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer. 2009, 45 (4): 625-633. 10.1016/j.ejca.2008.09.027.CrossRefPubMed Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M: Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer. 2009, 45 (4): 625-633. 10.1016/j.ejca.2008.09.027.CrossRefPubMed
35.
go back to reference Safaee A, Moghimi-Dehkordi B, Zeighami B, Tabatabaee H, Pourhoseingholi M: Predictors of quality of life in breast cancer patients under chemotherapy. Indian J Cancer. 2008, 45 (3): 107-111. 10.4103/0019-509X.44066.CrossRefPubMed Safaee A, Moghimi-Dehkordi B, Zeighami B, Tabatabaee H, Pourhoseingholi M: Predictors of quality of life in breast cancer patients under chemotherapy. Indian J Cancer. 2008, 45 (3): 107-111. 10.4103/0019-509X.44066.CrossRefPubMed
36.
go back to reference Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR: Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004, 96 (5): 376-387. 10.1093/jnci/djh060.CrossRefPubMed Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR: Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004, 96 (5): 376-387. 10.1093/jnci/djh060.CrossRefPubMed
Metadata
Title
Quality of life of Bahraini women with breast cancer: a cross sectional study
Authors
Ghufran Ahmed Jassim
David L Whitford
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-212

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine